Skip to main content
. Author manuscript; available in PMC: 2011 May 7.
Published in final edited form as: Vaccine. 2010 Mar 28;28(21):3672–3678. doi: 10.1016/j.vaccine.2010.03.022

Fig. 3. Percentages of circulating (A) CD19+ B cells and (B) CD19+CD27+ memory B cells that are CD21− in HIV uninfected and HIV infected donors and study subjects at entry, week 28 and week 72/76.

Fig. 3

Open diamonds represent aviremic HIV infected study subjects (plasma HIV-1 RNA <400 copies/ml) and closed diamonds represent viremic HIV infected study subjects (plasma HIV-1 RNA >400 copies/ml). Horizontal bars indicate significant differences between the HIV infected and HIV uninfected study subjects. Vertical bars indicate significant differences between the HIV aviremic study subjects and the HIV viremic subjects. Seven HIV uninfected (closed circles) and 6 HIV infected, viremic (closed squares) adult donors constituted the control population.